# FDA Inspection 868851 - Delta Blood Bank - February 28, 2014

Source: https://www.keypedia.com/records/fda_inspections/delta-blood-bank/83f074ad-392f-4b13-b785-12f2fdd2539e
Source feed: FDA_Inspections

> FDA Inspection 868851 for Delta Blood Bank on February 28, 2014. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 868851
- Company Name: Delta Blood Bank
- Inspection Date: 2014-02-28
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 931527 - 2015-06-19](https://www.keypedia.com/records/fda_inspections/delta-blood-bank/cde87df4-be35-4f05-b894-fa83946da583)
- [FDA Inspection 762518 - 2012-01-06](https://www.keypedia.com/records/fda_inspections/delta-blood-bank/e4217b3a-4b78-45d0-8427-060b6b7e68e0)
- [FDA Inspection 629683 - 2009-11-20](https://www.keypedia.com/records/fda_inspections/delta-blood-bank/be54ee3b-9f1c-4187-b6dc-991b9c15d040)
- [FDA Inspection 561291 - 2009-01-09](https://www.keypedia.com/records/fda_inspections/delta-blood-bank/b0648bef-be7a-4ad2-9f8d-9d34783cba3d)

Company: https://www.keypedia.com/companies/delta-blood-bank/830d4fef-974c-481a-b6a2-aa17976822e0

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d